Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 254 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Exenatide and Sitagliptin Decrease Interleukin 1ß, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis
Renata M. Moraes,Gabriela M. G. Lima,Felipe E. Oliveira,Ana Carolina V. Brito,Rodrigo C. Pereira,Luciane D. Oliveira,Patrícia P. Barros,Gilson C. N. Franco,Ana Lia Anbinder
Journal of Periodontology.2015;86(11)1287
[DOI]
2Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Francisco Kerr Saraiva,Andrei C Sposito
Cardiovascular Diabetology.2014;13(1)1287
[DOI]
3Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving ß-catenin
Xuelun Wu,Shilun Li,Peng Xue,Yukun Li
Experimental Cell Research.2017;360(2)281
[DOI]
4The regulation of function, growth and survival of GLP-1-producing L-cells
Rune E. Kuhre,Jens J. Holst,Camilla Kappe
Clinical Science.2016;130(2)79
[DOI]
5The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet
Rashmi Pathak,Avinash Kumar,Henry A. Palfrey,Laura A. Forney,Kirsten P. Stone,Narayan R. Raju,Thomas W. Gettys,Subramanyam N. Murthy
Inflammation Research.2019;68(7)581
[DOI]
6Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice
Ana Babic Perhoc,Jelena Osmanovic Barilar,Ana Knezovic,Vladimir Farkas,Robert Bagaric,Alfred Svarc,Edna Grünblatt,Peter Riederer,Melita Salkovic-Petrisic
Neuropharmacology.2019;148(7)50
[DOI]
7Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice
Deborah R. Gustafson,Samy I. McFarlane
Neuropharmacology.2018;148(7)5
[DOI]
8Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions
Annie Hasib
Clinical Medicine Insights: Endocrinology and Diabetes.2020;13(7)117955142090584
[DOI]
9Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes
Konosuke Nagae,Hiroshi Uchi,Saori Morino-Koga,Yuka Tanaka,Mari Oda,Masutaka Furue
Diabetes Research and Clinical Practice.2018;146(7)155
[DOI]
10BMI and BMD: The Potential Interplay between Obesity and Bone Fragility
Andrea Palermo,Dario Tuccinardi,Giuseppe Defeudis,Mikiko Watanabe,Luca D’Onofrio,Angelo Lauria Pantano,Nicola Napoli,Paolo Pozzilli,Silvia Manfrini
International Journal of Environmental Research and Public Health.2016;13(6)544
[DOI]
11Obesidad hipotalámica tras intervención quirúrgica de un craneofaringioma: tratamiento con un análogo del péptido similar al glucagón tipo 1
Inés Castro-Dufourny,Rodrigo Carrasco,José María Pascual
Endocrinología, Diabetes y Nutrición.2017;64(3)182
[DOI]
12PROSPECTS OF NEPHROPROTECTION AGAINST TYPE 2 DIABETES USING THE DPP-4 INHIBITOR VILDAGLIPTIN
V. K. Bayrasheva,A. Y. Babenko,A. A. Bayramov,S. G. Chefu,I. S. Shatalov,I. Y. Pchelin,A. N. Arefieva,E. N. Grineva
Medical Council.2017;64(3)8
[DOI]
13Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review
Weimin Ni,Xiang'en Shi
World Neurosurgery.2018;118(3)e59
[DOI]
14Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Silvano Paternoster,Marco Falasca
Frontiers in Endocrinology.2018;9(3)e59
[DOI]
15GLP-1R activation for the treatment of stroke: Updating and future perspectives
Vladimer Darsalia,David Nathanson,Thomas Nyström,Thomas Klein,Åke Sjöholm,Cesare Patrone
Reviews in Endocrine and Metabolic Disorders.2014;15(3)233
[DOI]
16Hypothalamic obesity after craniopharyngioma surgery: Treatment with a long acting glucagon like peptide 1 derivated
Inés Castro-Dufourny,Rodrigo Carrasco,José María Pascual
Endocrinología, Diabetes y Nutrición (English ed.).2017;64(3)182
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal